- Home
- PRTH vs PHAR Comparison
PRTH vs PHAR Comparison
Compare PRTH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTH
- PHAR
- Stock Information
- Founded
- PRTH 2005
- PHAR 1988
- Country
- PRTH United States
- PHAR Netherlands
- Employees
- PRTH N/A
- PHAR N/A
- Industry
- PRTH EDP Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PRTH Technology
- PHAR Health Care
- Exchange
- PRTH Nasdaq
- PHAR Nasdaq
- Market Cap
- PRTH 622.1M
- PHAR 731.1M
- IPO Year
- PRTH N/A
- PHAR N/A
- Fundamental
- Price
- PRTH $7.35
- PHAR $10.00
- Analyst Decision
- PRTH Strong Buy
- PHAR Strong Buy
- Analyst Count
- PRTH 4
- PHAR 3
- Target Price
- PRTH $12.25
- PHAR $30.00
- AVG Volume (30 Days)
- PRTH 748.0K
- PHAR 3.6K
- Earning Date
- PRTH 08-07-2025
- PHAR 07-31-2025
- Dividend Yield
- PRTH N/A
- PHAR N/A
- EPS Growth
- PRTH N/A
- PHAR N/A
- EPS
- PRTH N/A
- PHAR N/A
- Revenue
- PRTH $898,613,000.00
- PHAR $320,708,000.00
- Revenue This Year
- PRTH $12.70
- PHAR $13.31
- Revenue Next Year
- PRTH $10.34
- PHAR $7.68
- P/E Ratio
- PRTH N/A
- PHAR N/A
- Revenue Growth
- PRTH 15.76
- PHAR 24.13
- 52 Week Low
- PRTH $4.13
- PHAR $6.65
- 52 Week High
- PRTH $12.47
- PHAR $12.61
- Technical
- Relative Strength Index (RSI)
- PRTH 39.62
- PHAR 43.61
- Support Level
- PRTH $7.95
- PHAR $9.99
- Resistance Level
- PRTH $8.89
- PHAR $10.59
- Average True Range (ATR)
- PRTH 0.44
- PHAR 0.35
- MACD
- PRTH -0.03
- PHAR -0.14
- Stochastic Oscillator
- PRTH 1.28
- PHAR 7.45
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.